Susanna Fryer, PhD

Title(s)Associate Professor, Psychiatry
SchoolSchool of Medicine
Address401 Parnassus Ave.
San Francisco CA 94143
Phone415-221-4810 ext. 6358
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    Stanford UniversityB.A.00Human Biology
    SDUS/UCSF Joint Doctoral Program in Clinical PsychologyPhD2009subfield: neuropsychology
    San Francisco VA Medical CenterClinical Psychology Internship2009

    Collapse Research 
    Collapse Research Activities and Funding
    Using electrophysiology to index non-invasive brain stimulation effects on reward system neurobiology in depression
    NIH R21MH127432Jul 1, 2021 - Jun 30, 2023
    Role: Principal Investigator
    Reward processing and depressive subtypes: Identifying neural biotypes related to suicide risk, resilience, and treatment response
    VA CX001980Oct 1, 2020 - Sep 30, 2024
    Role: Principal Investigator
    Reward processing and depressive subtypes: Identifying neural biotypes related to suicide risk, resilience, and treatment response
    NIH I01CX001980Oct 1, 2020 - Sep 30, 2024
    Role: Principal Investigator
    Multimodal Neural Investigation of Reward Processing in Schizophrenia
    NIH IK2CX001028Jul 1, 2014 - Jun 30, 2019
    Role: Principal Investigator
    Default mode connectivity in typical development & the schizophrenia prodrome
    NIH F32MH095404Sep 1, 2012 - Aug 31, 2014
    Role: Principal Investigator
    Brain Imaging in Fetal Alcohol Exposed Delinquents
    NIH F31AA016051Sep 16, 2005 - Sep 15, 2008
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia. Mol Psychiatry. 2022 05; 27(5):2448-2456. Abram SV, Roach BJ, Fryer SL, Calhoun VD, Preda A, van Erp TGM, Bustillo JR, Lim KO, Loewy RL, Stuart BK, Krystal JH, Ford JM, Mathalon DH. PMID: 35422467; PMCID: PMC9135621.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Psychological Dimensions Relevant to Motivation and Pleasure in Schizophrenia. Front Behav Neurosci. 2022; 16:827260. Abram SV, Weittenhiller LP, Bertrand CE, McQuaid JR, Mathalon DH, Ford JM, Fryer SL. PMID: 35401135; PMCID: PMC8985863.
      View in: PubMed   Mentions:
    3. Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression. Psychopharmacology (Berl). 2021 Nov; 238(11):3229-3237. Pennybaker S, Roach BJ, Fryer SL, Badathala A, Wallace AW, Mathalon DH, Marton TF. PMID: 34363507.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    4. Advanced Brain Age Corresponds With Increased Rumination and Decreased Mindfulness in Schizophrenia. Biological Psychiatry. 2021 May 1; 89(9):s178-s179. Abram AS, Roach RB, Hua HJ, Mathalon MD, Ford FJ, Fryer FS. .
      View in: Publisher Site   Mentions:
    5. Cortical and Subcortical Brain Morphometry Abnormalities in Youth at Clinical High Risk for Psychosis and Individuals With Early Illness Schizophrenia. Biological Psychiatry. 2021 May 1; 89(9):s369. Hua HJ, Roach RB, Fryer FS, Loewy LR, Vinogradov VS, Carter CC, Niendam NT, Mathalon MD. .
      View in: Publisher Site   Mentions:
    6. Response to targeted cognitive training may be neuroprotective in patients with early schizophrenia. Psychiatry Res Neuroimaging. 2021 06 30; 312:111285. Ramsay IS, Fryer S, Roach BJ, Boos A, Fisher M, Loewy R, Ford JM, Vinogradov S, Mathalon DH. PMID: 33865147; PMCID: PMC8137670.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. Thalamic dysconnectivity in the psychosis risk syndrome and early illness schizophrenia. Psychol Med. 2021 Mar 15; 1-9. Fryer SL, Ferri JM, Roach BJ, Loewy RL, Stuart BK, Anticevic A, Ford JM, Mathalon DH. PMID: 33719985.
      View in: PubMed   Mentions: 1     Fields:    
    8. Electrophysiological investigation of reward anticipation and outcome evaluation during slot machine play. Neuroimage. 2021 05 15; 232:117874. Fryer SL, Roach BJ, Holroyd CB, Paulus MP, Sargent K, Boos A, Ford JM, Mathalon DH. PMID: 33609667.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Doubling Down on Developing Reward System Neurobiology Markers of Antidepressant Treatment Response. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 01; 6(1):3-5. Fryer SL. PMID: 33419510.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Reward processing electrophysiology in schizophrenia: Effects of age and illness phase. Neuroimage Clin. 2020; 28:102492. Abram SV, Roach BJ, Holroyd CB, Paulus MP, Ford JM, Mathalon DH, Fryer SL. PMID: 33395983; PMCID: PMC7695886.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis. J Abnorm Psychol. 2020 Aug; 129(6):599-611. Fryer SL, Roach BJ, Hamilton HK, Bachman P, Belger A, Carrión RE, Duncan E, Johannesen J, Light GA, Niznikiewicz M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman L, Tsuang M, Walker EF, Woods SW, Mathalon DH. PMID: 32757603; PMCID: PMC7430496.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    12. Deficits in Auditory Predictive Coding in Individuals With the Psychosis Risk Syndrome: Prediction of Conversion to Psychosis. Biological Psychiatry. 2020 May 1; 87(9):s117-s118. Fryer FS, Roach RB, Hamilton HH, Bachman BP, Belger BA, Carrion CR, Duncan DE, Johannesen JJ, Light LG, Niznikiewicz NM, Addington AJ, Bearden BC, Cadenhead CK, Cannon CT, Cornblatt CB, McGlashan MT, Perkins PD, Seidman SL, Tsuang TM, Walker WE, Woods WS, Mathalon MD. .
      View in: Publisher Site   Mentions:
    13. Reward Processing Electrophysiology in Schizophrenia Depends on Age and Illness Phase. Biological Psychiatry. 2020 May 1; 87(9):s333. Abram AS, Roach RB, Holroyd HC, Paulus PM, Ford FJ, Mathalon MD, Fryer FS. .
      View in: Publisher Site   Mentions:
    14. Increased global cognition correlates with increased thalamo-temporal connectivity in response to targeted cognitive training for recent onset schizophrenia. Schizophr Res. 2020 04; 218:131-137. Ramsay IS, Roach BJ, Fryer S, Fisher M, Loewy R, Ford JM, Vinogradov S, Mathalon DH. PMID: 32007346; PMCID: PMC7299776.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    15. O17. Mindfulness-Based Cognitive Therapy Modulates Functional Brain Activation During Affective Distraction in Treatment-Resistant Depression: A Randomized Controlled Study. Biological Psychiatry. 2019 May 1; 85(10):s112. Fryer FS, Eisendrath ES, Segal SZ, Roach RB, Ford FJ, Mathalon MD, Gillung GE. .
      View in: Publisher Site   Mentions:
    16. O8.2. CHANGES IN FRONTAL AND TEMPORAL CORTICAL THICKNESS CORRELATE WITH GLOBAL COGNITIVE CHANGES FOLLOWING TARGETED COGNITIVE TRAINING IN SCHIZOPHRENIA. Schizophrenia Bulletin. 2019 Apr 9; 45(Supplement_2):s183-s184. Ramsay RI, Fryer FS, Roach RB, Boos BA, Fisher FM, Loewy LR, Ford FJ, Vinogradov VS, Mathalon MD. .
      View in: Publisher Site   Mentions:
    17. Should I Stay or Should I Go? FMRI Study of Response Inhibition in Early Illness Schizophrenia and Risk for Psychosis. Schizophr Bull. 2019 01 01; 45(1):158-168. Fryer SL, Roach BJ, Ford JM, Donaldson KR, Calhoun VD, Pearlson GD, Kiehl KA, Srihari VH, McGlashan TH, Woods SW, Mathalon DH. PMID: 29385625; PMCID: PMC6293268.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    18. Transient Patterns of Functional Dysconnectivity in Clinical High Risk and Early Illness Schizophrenia Individuals Compared with Healthy Controls. Brain Connect. 2019 02; 9(1):60-76. Mennigen E, Fryer SL, Rashid B, Damaraju E, Du Y, Loewy RL, Stuart BK, Calhoun VD, Mathalon DH. PMID: 29855202; PMCID: PMC6390658.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    19. Reduced higher-dimensional resting state fMRI dynamism in clinical high-risk individuals for schizophrenia identified by meta-state analysis. Schizophr Res. 2018 11; 201:217-223. Mennigen E, Miller RL, Rashid B, Fryer SL, Loewy RL, Stuart BK, Mathalon DH, Calhoun VD. PMID: 29907493; PMCID: PMC6252113.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    20. F224. Thalamic Dysconnectivity in the Psychosis Risk Syndrome and Early Illness Schizophrenia. Biological Psychiatry. 2018 May 1; 83(9):s325-s326. Ford FJ, Ferri FJ, Roach RB, Fryer FS, Stuart SB, Loewy LR, Mathalon MD. .
      View in: Publisher Site   Mentions:
    21. T217. Measures of Neural Oscillation Synchrony During Reward Processing in Schizophrenia. Biological Psychiatry. 2018 May 1; 83(9):s212-s213. Fryer FS, Roach RB, Ford FJ, Gokbayrak GN, Boos BA, Mathalon MD. .
      View in: Publisher Site   Mentions:
    22. T258. Increased Thalamo-Temporal Connectivity Following Targeted Cognitive Training in Schizophrenia. Biological Psychiatry. 2018 May 1; 83(9):s229-s230. Ramsay RI, Roach RB, Fryer FS, Fisher FM, Loewy LR, Vinogradov VS, Mathalon MD. .
      View in: Publisher Site   Mentions:
    23. Blunted amygdala activity is associated with depression severity in treatment-resistant depression. Cogn Affect Behav Neurosci. 2017 12; 17(6):1221-1231. Ferri J, Eisendrath SJ, Fryer SL, Gillung E, Roach BJ, Mathalon DH. PMID: 29063521; PMCID: PMC5728990.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    24. Identifying functional network changing patterns in individuals at clinical high-risk for psychosis and patients with early illness schizophrenia: A group ICA study. Neuroimage Clin. 2018; 17:335-346. Du Y, Fryer SL, Lin D, Sui J, Yu Q, Chen J, Stuart B, Loewy RL, Calhoun VD, Mathalon DH. PMID: 29159045; PMCID: PMC5681342.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    25. Dynamic functional connectivity impairments in early schizophrenia and clinical high-risk for psychosis. Neuroimage. 2018 10 15; 180(Pt B):632-645. Du Y, Fryer SL, Fu Z, Lin D, Sui J, Chen J, Damaraju E, Mennigen E, Stuart B, Loewy RL, Mathalon DH, Calhoun VD. PMID: 29038030; PMCID: PMC5899692.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    26. Response to Targeted Cognitive Training Correlates with Change in Thalamic Volume in a Randomized Trial for Early Schizophrenia. Neuropsychopharmacology. 2018 02; 43(3):590-597. Ramsay IS, Fryer S, Boos A, Roach BJ, Fisher M, Loewy R, Vinogradov S, Mathalon DH. PMID: 28895568; PMCID: PMC5770762.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    27. 77. Thalamic Dysconnectivity in Individuals at Clinically High Risk for Schizophrenia and During Early Illness. Schizophrenia Bulletin. 2017 Mar 1; 43(suppl_1):s44-s44. Ferri FJ, Fryer FS, Roach RB, Loewy LR, Ford FJ, Mathalon MD. .
      View in: Publisher Site   Mentions:
    28. 76. fMRI Response During Error Processing in Clinical High Risk and Early Illness Schizophrenia. Schizophrenia Bulletin. 2017 Mar 1; 43(suppl_1):s43-s44. Fryer FS, Townsend TJ, Ford FJ, Roach RB, Calhoun CV, Pearlson PG, Kiehl KK, Srihari SV, Woods WS, McGlashan MT, Mathalon MD. .
      View in: Publisher Site   Mentions:
    29. 90. Targeted Cognitive Training is Neuroprotective Against Thalamic Volume Loss in Early Schizophrenia. Schizophrenia Bulletin. 2017 Mar 1; 43(suppl_1):s49-s49. Ramsay RI, Fryer FS, Boos BA, Roach RB, Fisher FM, Loewy LR, Vinogradov VS, Mathalon MD. .
      View in: Publisher Site   Mentions:
    30. Action-based predictive coding is abnormal in psychotic patients. International Journal of Psychophysiology. 2016 Oct 1; 108:13. Ford FJ, Palzes PV, Roach RB, Fryer FS, Mathalon MD. .
      View in: Publisher Site   Mentions:
    31. Reduced Amplitude of Low-Frequency Brain Oscillations in the Psychosis Risk Syndrome and Early Illness Schizophrenia. Neuropsychopharmacology. 2016 08; 41(9):2388-98. Fryer SL, Roach BJ, Wiley K, Loewy RL, Ford JM, Mathalon DH. PMID: 27067126; PMCID: PMC4946069.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    32. The effect of cognitive challenge on delay discounting. Neuroimage. 2016 Jan 01; 124(Pt A):733-739. Aranovich GJ, McClure SM, Fryer S, Mathalon DH. PMID: 26394377; PMCID: PMC5858572.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    33. Relating Intrinsic Low-Frequency BOLD Cortical Oscillations to Cognition in Schizophrenia. Neuropsychopharmacology. 2015 Nov; 40(12):2705-14. Fryer SL, Roach BJ, Ford JM, Turner JA, van Erp TG, Voyvodic J, Preda A, Belger A, Bustillo J, O'Leary D, Mueller BA, Lim KO, McEwen SC, Calhoun VD, Diaz M, Glover G, Greve D, Wible CG, Vaidya J, Potkin SG, Mathalon DH. PMID: 25944410; PMCID: PMC4864646.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    34. Deficient Suppression of Default Mode Regions during Working Memory in Individuals with Early Psychosis and at Clinical High-Risk for Psychosis. Front Psychiatry. 2013; 4:92. Fryer SL, Woods SW, Kiehl KA, Calhoun VD, Pearlson GD, Roach BJ, Ford JM, Srihari VH, McGlashan TH, Mathalon DH. PMID: 24032017; PMCID: PMC3768116.
      View in: PubMed   Mentions: 31  
    35. Differential brain response to alcohol cue distractors across stages of alcohol dependence. Biol Psychol. 2013 Feb; 92(2):282-91. Fryer SL, Jorgensen KW, Yetter EJ, Daurignac EC, Watson TD, Shanbhag H, Krystal JH, Mathalon DH. PMID: 23131612; PMCID: PMC3947923.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    36. Effect of predictive cuing on response inhibition in children with heavy prenatal alcohol exposure. Alcohol Clin Exp Res. 2013 Apr; 37(4):644-54. O'Brien JW, Norman AL, Fryer SL, Tapert SF, Paulus MP, Jones KL, Jones KL, Riley EP, Mattson SN. PMID: 23094678; PMCID: PMC3771541.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    37. Associations of Cigarette Smoking and Polymorphisms in Brain-Derived Neurotrophic Factor and Catechol-O-Methyltransferase with Neurocognition in Alcohol Dependent Individuals during Early Abstinence. Front Pharmacol. 2012; 3:178. Durazzo TC, Hutchison KE, Fryer SL, Mon A, Meyerhoff DJ. PMID: 23087644; PMCID: PMC3469037.
      View in: PubMed   Mentions: 5  
    38. Another step forward in relating facial and brain dysmorphologies associated with prenatal alcohol exposure. Alcohol Clin Exp Res. 2012 Jul; 36(7):1131-3. Fryer SL. PMID: 22780985; PMCID: PMC4034685.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    39. Caudate volume predicts neurocognitive performance in youth with heavy prenatal alcohol exposure. Alcohol Clin Exp Res. 2012 Nov; 36(11):1932-41. Fryer SL, Mattson SN, Jernigan TL, Archibald SL, Jones KL, Riley EP. PMID: 22551091; PMCID: PMC3723132.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    40. Cortical thickness, surface area, and volume of the brain reward system in alcohol dependence: relationships to relapse and extended abstinence. Alcohol Clin Exp Res. 2011 Jun; 35(6):1187-200. Durazzo TC, Tosun D, Buckley S, Gazdzinski S, Mon A, Fryer SL, Meyerhoff DJ. PMID: 21410483; PMCID: PMC3097308.
      View in: PubMed   Mentions: 126     Fields:    Translation:HumansPHPublic Health
    41. Measures of learning, memory and processing speed accurately predict smoking status in short-term abstinent treatment-seeking alcohol-dependent individuals. Alcohol Alcohol. 2010 Nov-Dec; 45(6):507-13. Durazzo TC, Fryer SL, Rothlind JC, Vertinski M, Gazdzinski S, Mon A, Meyerhoff DJ. PMID: 20923865; PMCID: PMC2981519.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    42. Cingulate gyrus morphology in children and adolescents with fetal alcohol spectrum disorders. Psychiatry Res. 2010 Feb 28; 181(2):101-7. Bjorkquist OA, Fryer SL, Reiss AL, Mattson SN, Riley EP. PMID: 20080394; PMCID: PMC2815126.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    43. BOLD response during spatial working memory in youth with heavy prenatal alcohol exposure. Alcohol Clin Exp Res. 2009 Dec; 33(12):2067-76. Spadoni AD, Bazinet AD, Fryer SL, Tapert SF, Mattson SN, Riley EP. PMID: 19740135; PMCID: PMC2789890.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    44. Characterization of white matter microstructure in fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2009 Mar; 33(3):514-21. Fryer SL, Schweinsburg BC, Bjorkquist OA, Frank LR, Mattson SN, Spadoni AD, Riley EP. PMID: 19120066; PMCID: PMC2651988.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    45. Microstructural integrity of the corpus callosum linked with neuropsychological performance in adolescents. Brain Cogn. 2008 Jul; 67(2):225-33. Fryer SL, Frank LR, Spadoni AD, Theilmann RJ, Nagel BJ, Schweinsburg AD, Tapert SF. PMID: 18346830; PMCID: PMC2491343.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    46. Deficits in social problem solving in adolescents with prenatal exposure to alcohol. Am J Drug Alcohol Abuse. 2008; 34(4):423-31. McGee CL, Fryer SL, Bjorkquist OA, Mattson SN, Riley EP. PMID: 18584572.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    47. Prenatal alcohol exposure affects frontal-striatal BOLD response during inhibitory control. Alcohol Clin Exp Res. 2007 Aug; 31(8):1415-24. Fryer SL, Tapert SF, Mattson SN, Paulus MP, Spadoni AD, Riley EP. PMID: 17559542.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    48. Evaluation of psychopathological conditions in children with heavy prenatal alcohol exposure. Pediatrics. 2007 Mar; 119(3):e733-41. Fryer SL, McGee CL, Matt GE, Riley EP, Mattson SN. PMID: 17332190.
      View in: PubMed   Mentions: 106     Fields:    Translation:HumansPHPublic Health
    49. Neuroimaging and fetal alcohol spectrum disorders. Neurosci Biobehav Rev. 2007; 31(2):239-45. Spadoni AD, McGee CL, Fryer SL, Riley EP. PMID: 17097730; PMCID: PMC1820628.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    50. Influence of Alcohol on Structure of the Developing Human Brain. . 2006 May 25; 143-152. Fryer FS, McGee MC, Spadoni SA, Riley RE. .
      View in: Publisher Site   Mentions:
    51. Lessons Learned. Human Developmental Neurotoxicology. 2006 Apr 6; 169-191. Fryer FS, McGee MC, Mattson MS. .
      View in: Publisher Site   Mentions:
    52. ADAPTIVE FUNCTIONING DIFFERENCES BY ASCERTAINMENT METHOD IN CHILDREN PRENATALLY EXPOSED TO ALCOHOL. Alcoholism Clinical and Experimental Research. 2004 Aug 1; 28(8):27a. McGee MC, Fryer FS, Riley RE, Coles CC, Kodituwakku KP, May MP, Kalberg KW, Mattson MS. .
      View in: Publisher Site   Mentions:
    53. Investigation of neuroanatomical differences between autism and Asperger syndrome. Arch Gen Psychiatry. 2004 Mar; 61(3):291-8. Lotspeich LJ, Kwon H, Schumann CM, Fryer SL, Goodlin-Jones BL, Buonocore MH, Lammers CR, Amaral DG, Reiss AL. PMID: 14993117.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    54. Corpus callosum and posterior fossa development in monozygotic females: a morphometric MRI study of Turner syndrome. Dev Med Child Neurol. 2003 May; 45(5):320-4. Fryer SL, Kwon H, Eliez S, Reiss AL. PMID: 12729146.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    Susanna's Networks
    Concepts (141)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (32)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-880-g43f982f8 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California